Patents Assigned to LEADGENEX INC.
  • QUINAZOLINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DIABETES AND OBESITY
    Publication number: 20080207614
    Abstract: The present invention relates to novel quinazoline derivatives effective in lowering blood glucose level and body weight, and a medicine for treatment and/or prevention of diabetes and/or obesity, which comprises the compound as an active ingredient.
    Type: Application
    Filed: June 29, 2007
    Publication date: August 28, 2008
    Applicants: SK CHEMICALS CO., LTD., LEADGENEX INC., INDUSTRY ACADEMIC COOPERATION FOUNDATION OF KYUNGHEE UNIVERSITY
    Inventors: Nam Kyu Lee, Jun Won Lee, Sukho Lee, Guang-Jin Im, Hye Young Han, Tae Kon Kim, Yong Hyuk Kim, Wie-Jong Kwak, Sang Woong Kim, Joohun Ha, Eon Kyum Kim, Jung Kyu Lee, Choong Yeul Yoo, Dae Yeon Lee